Most Recent
A judge has dispensed with the opt out notice requirement in two class actions filed in administration proceedings related to the spectacular collapse of HIH Insurance.
JP Morgan, the reported whistleblower behind a criminal cartel case against ANZ, Deutsche Bank and Citigroup over a $2.5 billion share placement, has won its bid to keep documents from a related ASIC probe confidential.
Defunct financial adviser Dover Financial is seeking evidence to bolster its argument that no clients were harmed by a liability waiver that's at the centre of a lawsuit by the Australian Securities and Investments Commission.
The Australian Securities and Investments Commission has not ruled out a challenge to a ruling that two Westpac subsidiaries didn't provide personal financial advice as part of a campaign encouraging customers to roll over external superannuation accounts.
French pharmaceutical giant Sanofi has appealed a judge's ruling denying its bid to block Alphapharm from listing an insulin injector pen on the Pharmaceutical Benefit Scheme.
Unilever's allegations that consumer goods competitor Beiersdorf made misleading claims about its Nivea clinical strength deodorant products don't pass the smell test, a judge has found.
Generic drug giant Teva has filed a lawsuit seeking to have German pharmaceutical company Boehringer's patent for an inhalation capsule, which is used to deliver the active drug in its blockbuster Spiriva asthma inhaler, declared invalid.
A judge has slammed an amended pleading in a class action against Zoetis by horse owners who claim the pharmaceutical company made misleading claims about its Hendra virus drug, saying it presents an "insuperable difficulty".
A judge has denied Sanofi's bid to block Alphapharm from listing its insulin injector pen on the Pharmaceutical Benefit Scheme, saying Sanofi has not established a strong enough case of infringement to justify granting the injunction.
In observance of the Christmas holiday, Lawyerly will be closed from 24 December through 4 January. We will resume regular daily publishing and newsletter distribution on Monday, 7 January. If you have any trouble accessing your Lawyerly account or wish to purchase a subscription during this time, please email subscriptions@lawyerly.com.au.